MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Cartesian Therapeutics Inc

Uždarymo kaina

8.95 -4.38

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.84

Max

9.09

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+346.17% upside

Cartesian Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-17 18:13; UTC

Pagrindinės rinkos jėgos

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

2025-10-17 17:05; UTC

Pagrindinės rinkos jėgos

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

2025-10-18 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

2025-10-18 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

2025-10-18 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

2025-10-18 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

2025-10-18 08:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-10-18 07:00; UTC

Uždarbis

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

2025-10-17 23:25; UTC

Įsigijimai, susijungimai, perėmimai

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

2025-10-17 22:15; UTC

Rinkos pokalbiai

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

2025-10-17 21:15; UTC

Rinkos pokalbiai

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 20:34; UTC

Rinkos pokalbiai

Deere Is Reaching the End of Its Downcycle -- Market Talk

2025-10-17 20:27; UTC

Rinkos pokalbiai

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

2025-10-17 19:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

2025-10-17 19:45; UTC

Rinkos pokalbiai

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

2025-10-17 18:45; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

2025-10-17 17:44; UTC

Rinkos pokalbiai

EQT Seen With Long-Term Growth Opportunities -- Market Talk

2025-10-17 17:35; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 16:14; UTC

Rinkos pokalbiai

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

2025-10-17 16:04; UTC

Rinkos pokalbiai

Home Improvement Demand Is Starting to Pick Up -- Market Talk

2025-10-17 15:58; UTC

Rinkos pokalbiai

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

2025-10-17 15:56; UTC

Uždarbis

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

2025-10-17 15:43; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Cartesian Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

346.17% į viršų

12 mėnesių prognozė

Vidutinis 40.2 USD  346.17%

Aukščiausias 42 USD

Žemiausias 39 USD

Remiantis 7 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cartesian Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

7 ratings

6

Pirkti

1

Laikyti

0

Parduoti

Finansinės naujienos

$

help-icon Live chat